EuBioNet retweeted
Open calls for European Gram Negative Anti-Bacterial Engine, click for details of funding ow.ly/uHQvt #microbiology #antibiotics
IMI call for novel G Neg anti-infectives. Deadline sept 9 for 3 pg EoI with support webinars for applicants.
nd4bb-enable.eu/open-calls
IMI project ENABLE showcased at BIO San Diego. Visit nd4bb-enable.eu for slides from GSK, @MedinaDiscovery , Asclepia and Redx Pharma
€85m European project for novel antibiotics: ENABLE.
A 6 yr project aims to bring gram negative candidates to trial.
european-biotechnology.net/a…
Workshop: H2020 as strategic business tools for life science SMEs. March 27, Brussels. Free to EBN Corporate members.
european-biotechnology.net/e…
EuBioNet retweeted
#Roche and #Molecular #Partners team up in a CHF1bn deal to develop a #novel #class of #anti-#cancer #conjugates. european-biotechnology-news.…
EuBioNet retweeted
#PacBio and the #UK's #Sanger Institute team up to analyse the #genomes of 3,000 #pathogens by #SMRT #sequencing. european-biotechnology-news.…
New network event coming up! Join us on the #webinar on #bigdata in collaborative research See bit.ly/1et8UvO for more.
EuBioNet retweeted
Dutch-US investment firm #Gilde #Healthcare has #closed a €145m transatlantic growth capital #fund. european-biotechnology-news.…
Join us for World #Bio #Markets 2014! #EuroBioNet members get 20% #discount! Details on: bit.ly/1dxXLxp
EuBioNet retweeted
A new #centre dedicated to perform first-in-man #trials in #neurodegenerative #disorders has been #opened in London. european-biotechnology-news.…
EuBioNet retweeted
The EMA has postponed the implementation of new rules for disclosing clinical raw trial data. eurobiotechnews.eu/news/news…
EuBioNet retweeted
Belgian #Galapagos British subsidiary #BioFocus will screen and validate new #scleroderma targets for #Biogen Idec. eurobiotechnews.eu/news/news…
EuBioNet retweeted
#Shire plc gets a foothold in the #orphan #drug business by swallowing US company #ViroPharma for US$4.2bn. eurobiotechnews.eu/news/news…
EuBioNet retweeted
#Spanish researchers have identified the protein that #switches #off the #human body's #hepatoprotective #system. eurobiotechnews.eu/news/news…
EuBioNet retweeted
#Roche's glyco-optimised CD20 blocker #Gazyva (obinutuzumab) #extends progression-free #survival compared to Rituxan. eurobiotechnews.eu/news/news…
EuBioNet retweeted
The UK's BBSRC has kicked off an £10m #investment #fund dedicated to #biotechs that are active in #synthetic #biology.eurobiotechnews.eu/news/news…



